Products

Back Share This Page

UltraClean DHA Omega

Support for Brain Health and Cognitive Function

UltraClean® DHA Omega contains a high ratio of DHA to EPA to help maintain brain health.

UltraClean® DHA Omega contains a high ratio of DHA to EPA. DHA is highly concentrated in brain cells and maintains brain health and function as well as supporting cognitive function. UltraClean® DHA Omega maintains DHA and EPA levels in breastfeeding women and supports healthy foetal development.

Serving Type: Soft Capsule
Available in Sizes: 60 soft capsules Dosage: Adults: Take 1-2 capsules one to two times a day, or as professionally prescribed.

Where to buy

Product Features

  • Supports brain health and brain function.
  • Maintains cognitive function.
  • Supports healthy foetal development.
  • Supports eye health.
  • UltraClean® DHA Omega helps to maintain omega-3 levels in breastfeeding women.

Ingredients

Concentrated omega-3 triglycerides - fish 1 g
equiv. to docosahexaenoic acid (DHA)500 mg
equiv. to eicosapentaenoic acid (EPA)100 mg

Warning

  • Always read the label and follow the directions for use.
  • Nutritional supplements can only be of assistance if dietary intake is inadequate.
  • Advise your doctor of any medicine you take during pregnancy, particularly in your first trimester.
  • Contains fish products, sulfites and soya bean products (lecithin). 
  • If you have any pre-existing conditions or are on any medications always talk to your health professional before use.
  • Some products should be ceased at least two weeks before any elective surgery, please confirm with your health professional.

Evidence

[1] Ramakrishnan U, Stein AD, Parra-Caberera S, et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double-blind, placebo-controlled trial in Mexico. Food Nutr Bull 2010;31(2 Suppl):S108-116.
[2] Jensen CL, Voigt RG, Llorente AM, et al. Effects of early maternal docosahexaenoic acid intake on neuropsychological status and visual acuity at five years of age of breast-fed term infants. J Pediatrics 2010, www.jpeds.com
[3] Imhoff-Kunsch B, Stein AD, Martorell R, et al. Prenatal docosahexaenoic acid supplementation and infant morbidity: randomized controlled trial. Pediatrics 2011;128(3), http://pediatrics.aappublications.org/content/early/2011/07/28/peds.2010-1386
[4] Wheaton DH, Hoffman DR, Locke KG, et al. Biological safety assessment of docosahexaenoic acid supplementation in a randomized clinical trial for X-linked retinitis pigmentosa. Arch Ophthalmol 2003;121(9):1269-1278.
[5] DHA (docosahexaenoic acid). Natural Medicines Comprehensive Database 2014. Viewed 30 May 2014, www.naturaldatabase.com
[6] Braun L, Cohen M. Herbs and natural supplements: an evidence-based guide, 3rd ed. Sydney: Churchill Livingstone Elsevier, 2010.
[7] Carlson SE. Docosahexaenoic acid supplementation in pregnancy and lactation. Am J Clin Nutr 2009;89(2):S678-S684.
[8] Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 2006;83(6 Suppl):S1467-S1476.
[9] Austria JA, Richard MN, Chahine MN, et al. Bioavailability of alpha-linolenic acid in subjects after ingestion of three different forms of flaxseed. J Am Coll Nutr 2008;27(2):214-221.
[10] Innis SM. Perinatal biochemistry and physiology of long-chain polyunsaturated fatty acids. J Pediatr 2003;143(4 Suppl):S1-S8,
[11] Helland IB, Smith L, Saarem K, et al. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age. Pediatrics 2003;111(1):e39-e44.
[12] Helland IB, Saugstand OD, Saarem K, et al. Supplementation of n-3 fatty acids during pregnancy and lactation reduces maternal plasma lipid levels and provides DHA to the infants. J Matern Fetal Neonatal Med 2006;19(7):397-406.
[13] Montgomery C, Speake BK, Cameron A, et al. Maternal docosahexaenoic acid supplementation and fetal accretion. Br J Nutr 2003;90(1):135-145.
[14] Szajewska H, Horvath A, Koletzko B. Effect of n-3 long-chain polyunsaturated fatty acid supplementation of women with low-risk pregnancies on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2006;83(6):1337-1344.
[15] Dutta-Roy AK. Transport mechanisms for long-chain polyunsaturated fatty acids in the human placenta. Am J Clin Nutr 2000;71(1 Suppl):S315S-S322.
[16] Jensen CL. Effects of n-3 fatty acids during pregnancy and lactation. Am J Clin Nutr 2006;83(6 Suppl):S1452-S1457.
[17] Parker G, Gibson NA, Brotchie H, et al. Omega-3 fatty acids and mood disorders. Am J Psychiatry 2006;163(6):969-978.
[18] Uauy R, Dangour AD. Nutrition in brain development and aging: role of essential fatty acids. Nutr Rev 2006;64(5 Pt 2):S24-S33.
[19] Larque E, Demmelmair H, Koletzko B. Perinatal supply and metabolism of long-chain polyunsaturated fatty acids: importance for the early development of the nervous system. Ann N Y Acad Sci 2002;967:299-310.

Conditions Associated


Dietary Influence


Customers who bought this also purchased


Please tell us your email address

Submit Cancel

That is an invalid email address

Quantity Required


Login Page Desktop Version